Suchergebnisse - "Yao, Hang-Ping"

PubPharm (87)

1

MONOCLONAL ANTIBODIES SPECIFIC TO THE PLEXIN-SEMAPHORIN-INTEGRIN (PSI) DOMAIN OF RON FOR DRUG DELIVERY AND ITS APPLICATION IN CANCER THERAPY

enthalten in: Europäisches Patentamt | 2019

von WANG MING-HAI | YAO HANG-PING

2

MONOCLONAL ANTIBODIES SPECIFIC TO THE PLEXIN-SEMAPHORIN-INTEGRIN (PSI) DOMAIN OF RON FOR DRUG DELIVERY AND ITS APPLICATION IN CANCER THERAPY

enthalten in: Europäisches Patentamt | 2019

von WANG MING-HAI | YAO HANG-PING

3

Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins

enthalten in: Engineering (Beijing, China) | 2019

von Li, Y. | Hu, C. | Wu, N. | +2

4

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

5

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

6

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

7

Correction to : Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

ErratumFor: J Immunother Cancer. 2019 Mar 14;7(1):75. - PMID 30871619

8

Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

9

Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

10

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

ErratumIn: J Immunother Cancer. 2019 Apr 2;7(1):94. - PMID 30940188

1
2
3
4
5
6
7
8
9
Nächster »
[9]